Manuel Stöth

12PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 10, 2026
The Influence of Cisplatin on Functionality and Surface Characteristics of Mesenchymal Stromal Cells In Vitro.

Armin von Fournier, Totta Ehret Kasemo, Miguel Goncalves

|Nov 27, 2025
Monotherapy With Immune Checkpoint Inhibitors in Patients With Recurrent and/or Metastatic Sinonasal Squamous Cell Carcinoma.

Alexander Lein, Thorsten Fuereder, Manuel Stoeth

|Sep 27, 2025
Blood-Based Inflammatory Markers Are Associated with Treatment Outcomes in Head and Neck Squamous Cell Carcinoma Receiving Anti-PD-1 Therapy: CRP as a Superior Predictive Marker.

Manuel Stöth, Flurin Müller-Diesing, Patricia Mack

|Jul 23, 2025
Cisplatin-Mediated IL-6 and IDO1 Suppression in Mesenchymal Stromal Cells: Implications for Tumor Microenvironment Modulation In Vitro.

Armin von Fournier, Erik Würflein, Helena Moratin

|Jan 11, 2025
Preconditioning with Wound Fluid Enhances Immunosuppressive Properties of Mesenchymal Stromal Cells In Vitro.

Helena Moratin, Isabel Mache, Miguel Goncalves

|May 24, 2024
A Tissue Engineered 3D Model of Cancer Cell Invasion for Human Head and Neck Squamous-Cell Carcinoma.

Manuel Stöth, Anna Teresa Mineif, Fabian Sauer

Pageof 2

Frequent Collaborators

8 joint publications

Stephan Hackenberg

6 joint publications

Till Meyer

2 joint publications

Mona Stefanakis

2 joint publications

Edwin Ostertag